For Immediate Release Duke University School of Medicine, Med-IQ to Host Complimentary CME Workshop Series for Primary Care Clinicians |
|||||||||||||||||||||||||||||||||||||||||||
BALTIMORE, MD—October 22, 2013—Registration is now underway for the complimentary, continuing medical education (CME) workshop series, Complex Cases in Primary Care 2013.
“Nearly 75 million Americans have two or more comorbid chronic conditions,” said Kathryn Andolsek, MD, MPH, Professor of Community and Family Medicine at Duke University School of Medicine. “Designed for primary care clinicians, by primary care clinicians, consulting with specialty colleagues, this interactive CME workshop series identifies practical solutions that incorporate the latest guideline- and evidence-based management strategies. Our goal is to enhance high value care and optimize our patients' outcomes.”
Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Duke University School of Medicine designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This Live activity, Complex Cases in Primary Care 2013, from October 26, 2013 to December 21, 2013, has been reviewed and is acceptable for up to 4.50 Prescribed credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This CME activity is supported by educational grants from Amgen, Astellas Pharma US, Inc., AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Endo Pharmaceuticals, Inc., Forest Laboratories, Inc., Lilly, Otsuka America Pharmaceutical, Inc., and independent educational grants from AbbVie and from Boehringer Ingelheim Pharmaceuticals, Inc., which was made possible, in part, through a collaboration with Eli Lilly and Company. For further information concerning Lilly grant funding visit lillygrantoffice.com. |
|||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Catherine B. Mullaney, MHA |